Risk Factors and Prognostic Analysis of Immune Checkpoint Inhibitor-Related Colitis in Lung Cancer
Shiyang Wang, Binhe Tian, Hanping Wang Division of Pulmonary and Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100730, People’s Republic of Chin...
Saved in:
| Main Authors: | Wang S, Tian B, Wang H |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2024-10-01
|
| Series: | Journal of Inflammation Research |
| Subjects: | |
| Online Access: | https://www.dovepress.com/risk-factors-and-prognostic-analysis-of-immune-checkpoint-inhibitor-re-peer-reviewed-fulltext-article-JIR |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preexisting ulcerative colitis increases the risk of immune-related colitis and predicts divergent survival outcomes in gastrointestinal cancer patients treated with immune checkpoint inhibitors
by: Shuo Xu, et al.
Published: (2025-08-01) -
The growing potential of tofacitinib in immune checkpoint inhibitor-induced colitis: identifying remaining puzzle pieces
by: Raffaele Pellegrino, et al.
Published: (2024-11-01) -
An updated review on immune checkpoint inhibitor-induced colitis: epidemiology, pathogenesis, treatment strategies, and the role of traditional Chinese medicine
by: Huijing Dong, et al.
Published: (2025-03-01) -
Clinical features of immune checkpoint inhibitor-related pneumonitis in older patients with lung cancer receiving immune checkpoint inhibitors-based therapy: a retrospective study
by: Jiafan Liu, et al.
Published: (2025-04-01) -
A case of refractory immune checkpoint inhibitor‐induced colitis with Clostridioides difficile infection
by: Yukito Okura, et al.
Published: (2023-04-01)